Law B - Search Results

1

Synthesis and evaluation of PEG414, a novel formulating agent that avoids analytical problems associated with polydisperse vehicles such as PEG400.

Temesi D, Law B, Howe N. Temesi D, et al. Among authors: law b. J Pharm Sci. 2003 Dec;92(12):2512-8. doi: 10.1002/jps.10514. J Pharm Sci. 2003. PMID: 14603497

2

Factors to consider in the development of generic bioanalytical high-performance liquid chromatographic-mass spectrometric methods to support drug discovery.

Law B, Temesi D. Law B, et al. J Chromatogr B Biomed Sci Appl. 2000 Oct 1;748(1):21-30. doi: 10.1016/s0378-4347(00)00319-4. J Chromatogr B Biomed Sci Appl. 2000. PMID: 11092583

3

The effect of eluent pH and compound acid-base character on the design of generic-gradient reversed-phase high-performance liquid chromatography (RP-HPLC) methods for use in drug discovery.

Law B. Law B. J Pharm Biomed Anal. 2004 Jan 27;34(1):215-9. doi: 10.1016/j.japna.2003.07.005. J Pharm Biomed Anal. 2004. PMID: 14738936

4

The development and evaluation of a diluter-ultraviolet spectrophotometric analysis system for the determination of drugs in solutions and suspensions.

Law B, Hough P. Law B, et al. J Pharm Biomed Anal. 1997 Feb;15(5):587-92. doi: 10.1016/s0731-7085(96)01882-1. J Pharm Biomed Anal. 1997. PMID: 9127270

5

An approach to the evaluation and comparison of reversed-phase high-performance liquid chromatography stationary phases.

Law B, Houghton SJ, Ballard P. Law B, et al. J Pharm Biomed Anal. 1998 Jul;17(3):443-53. doi: 10.1016/s0731-7085(97)00214-8. J Pharm Biomed Anal. 1998. PMID: 9656156

6

The application of strong cation exchange high-performance liquid chromatography to drug analysis.

Law B, Appleby JR. Law B, et al. J Pharm Biomed Anal. 1998 Sep 1;17(6-7):1199-203. doi: 10.1016/s0731-7085(98)00085-5. J Pharm Biomed Anal. 1998. PMID: 9884210

7

Re-evaluation of anion-exchange HPLC for the analysis of acidic compounds.

Law B, Hussain MA. Law B, et al. J Pharm Biomed Anal. 2000 Feb;22(1):149-54. doi: 10.1016/s0731-7085(99)00284-8. J Pharm Biomed Anal. 2000. PMID: 10727134

8

The use of competitive displacement agents to resolve albumin binding problems observed during the development of a radioimmunoassay for ICI 215001.

Ballard P, Malone MD, Law B. Ballard P, et al. Among authors: law b. J Pharm Biomed Anal. 1994 Jan;12(1):47-52. doi: 10.1016/0731-7085(94)80008-1. J Pharm Biomed Anal. 1994. PMID: 7909237

9

The discovery of benzanilides as c-Met receptor tyrosine kinase inhibitors by a directed screening approach.

Allen JV, Bardelle C, Blades K, Buttar D, Chapman L, Colclough N, Dossetter AG, Garner AP, Girdwood A, Lambert C, Leach AG, Law B, Major J, Plant H, Slater AM. Allen JV, et al. Among authors: law b. Bioorg Med Chem Lett. 2011 Sep 15;21(18):5224-9. doi: 10.1016/j.bmcl.2011.07.047. Epub 2011 Jul 23. Bioorg Med Chem Lett. 2011. PMID: 21835616

10

The design of pharmacokinetic studies to support drug discovery: the selection of the optimum number of animals for a study.

Law B, Temesi D. Law B, et al. Eur J Drug Metab Pharmacokinet. 2003 Jul-Sep;28(3):233-5. doi: 10.1007/BF03190490. Eur J Drug Metab Pharmacokinet. 2003. PMID: 14527097

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

977 results

Search Page

Filters